<DOC>
	<DOC>NCT01791322</DOC>
	<brief_summary>NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.</brief_summary>
	<brief_title>NovellusDx Tissue Collection Protocol</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Patients that have been diagnosed positive for colon cancer. available treatment follow up during cancer treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>